138 related articles for article (PubMed ID: 37462083)
1. Impact of BMI on the Survival of Renal Cell Carcinoma Patients Treated with Targeted Therapy: A Systematic Review and Meta-Analysis.
Ji J; Yao Y; Guan F; Luo L; Zhang G
Nutr Cancer; 2023; 75(9):1768-1782. PubMed ID: 37462083
[TBL] [Abstract][Full Text] [Related]
2. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.
Choi Y; Park B; Jeong BC; Seo SI; Jeon SS; Choi HY; Adami HO; Lee JE; Lee HM
Int J Cancer; 2013 Feb; 132(3):625-34. PubMed ID: 22610826
[TBL] [Abstract][Full Text] [Related]
3. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
4. The role of sarcopenia in treatment-related outcomes in patients with renal cell carcinoma: A systematic review and meta-analysis.
Yuxuan L; Junchao L; Wenya L
Medicine (Baltimore); 2022 Oct; 101(43):e31332. PubMed ID: 36316941
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen X; Meng F; Jiang R
Front Oncol; 2021; 11():746976. PubMed ID: 34900692
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis.
Fan Y; Li H; Ma X; Gao Y; Chen L; Li X; Bao X; Du Q; Zhang Y; Zhang X
Medicine (Baltimore); 2015 Sep; 94(38):e1646. PubMed ID: 26402839
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the platelet-lymphocyte ratio: A notable prognostic factor in renal cell carcinoma.
Zhou X; Luo G
Int J Biol Markers; 2022 Jun; 37(2):123-133. PubMed ID: 35238678
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
11. Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis.
Takemura K; Yonekura S; Downey LE; Evangelopoulos D; Heng DYC
Eur Urol Open Sci; 2022 May; 39():62-71. PubMed ID: 35528786
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Impact of Body Mass Index in Patients with Diffuse Large B-Cell Lymphoma: A Meta-Analysis.
Wang Z; Luo S; Zhao X
Nutr Cancer; 2021; 73(11-12):2336-2346. PubMed ID: 32964748
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis.
Lee WK; Hong SK; Lee S; Kwak C; Oh JJ; Jeong CW; Kim YJ; Kang SH; Hong SH; Byun SS
Clin Genitourin Cancer; 2015 Oct; 13(5):461-8. PubMed ID: 25990340
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shen J; Chen Z; Zhuang Q; Fan M; Ding T; Lu H; He X
PLoS One; 2016; 11(11):e0166482. PubMed ID: 27861542
[TBL] [Abstract][Full Text] [Related]
15. The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis.
Xu Y; Qi Y; Zhang J; Lu Y; Song J; Dong B; Kong W; Xue W; Huang Y
Tumour Biol; 2014 Jul; 35(7):6633-40. PubMed ID: 24699995
[TBL] [Abstract][Full Text] [Related]
16. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
18. Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab.
De Giorgi U; Procopio G; Giannarelli D; Sabbatini R; Bearz A; Buti S; Basso U; Mitterer M; Ortega C; Bidoli P; Ferraù F; Crinò L; Frassoldati A; Marchetti P; Mini E; Scoppola A; Verusio C; Fornarini G; Cartenì G; Caserta C; Sternberg CN
Clin Cancer Res; 2019 Jul; 25(13):3839-3846. PubMed ID: 30967420
[TBL] [Abstract][Full Text] [Related]
19. Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry.
Goebell PJ; Müller L; Hübner A; Harich HD; Boller E; Koska M; Jänicke M; Marschner N;
Urol Oncol; 2018 Oct; 36(10):470.e1-470.e9. PubMed ID: 30131294
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the prognosis of papillary and clear cell renal cell carcinoma: Evidence from a meta-analysis.
Deng J; Li L; Xia H; Guo J; Wu X; Yang X; Hong Y; Chen Q; Hu J
Medicine (Baltimore); 2019 Jul; 98(27):e16309. PubMed ID: 31277173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]